Handa Pharmaceuticals (ROCO:6620) EPS (Basic) : NT$3.20 (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Handa Pharmaceuticals EPS (Basic)?

Handa Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was NT$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$3.20.

Handa Pharmaceuticals's EPS (Diluted) for the three months ended in Dec. 2024 was NT$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$3.20.

Handa Pharmaceuticals's EPS without NRI for the three months ended in Dec. 2024 was NT$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 3.20.

During the past 12 months, Handa Pharmaceuticals's average EPS without NRIGrowth Rate was -37.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Handa Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 41.20% per year. The lowest was -13.40% per year. And the median was 5.90% per year.

Handa Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Handa Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handa Pharmaceuticals EPS (Basic) Chart

Handa Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-2.38

-2.07

-0.32

5.41

3.37

Handa Pharmaceuticals Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															1.07	0.57	0.83	0.73	-

Handa Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Handa Pharmaceuticals's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(472.743	-	0)	/	140.280
	=	3.37

Handa Pharmaceuticals's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0	-	0)	/	140.280
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.20

Handa Pharmaceuticals (ROCO:6620) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Handa Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Handa Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Handa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handa Pharmaceuticals Inc (ROCO:6620) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nanke 3rd Road, 3F-1,3F-2, No.23, Xinshi Dist, Tainan, TWN, 74147

Website

https://www.handapharma.com.tw

Handa Pharmaceuticals Inc is a Taiwan-based specialty pharmaceutical company. It is engaged in the development of niche drugs. The company focuses on the development of high-barrier/patentable niche products.

Handa Pharmaceuticals Headlines

No Headlines